Nikhil Prasad Fact checked by:Thailand Medical News Team Jul 03, 2026 1 hour, 3 minutes ago
Medical News: Diet Shows Promise but No Clear Proof It Helps Patients Live Longer
For years, the ketogenic diet has attracted attention as a possible way to help fight aggressive brain cancers by starving tumors of the sugar they need to grow. However, a new comprehensive review suggests that while the diet appears to be safe for many patients and can successfully trigger ketosis, there is still no convincing evidence that it improves survival or quality of life.
A comprehensive review finds ketogenic diets are generally safe for glioma patients but current evidence does not show
they improve survival or quality of life
Researchers from the University of Bologna, University of Eastern Piedmont, University of Florence, University of Milan, Istituto Auxologico Italiano IRCCS, the Italian Society of Hygiene and Preventive Medicine, University of Rome Foro Italico, and the University of Naples "Parthenope" carefully examined all available human studies on ketogenic diets for malignant gliomas, including glioblastoma, one of the deadliest forms of brain cancer.
Why Scientists Have Been Studying the Ketogenic Diet
Gliomas are among the most aggressive brain tumors and are notoriously difficult to treat. Standard treatment usually involves surgery followed by radiation and chemotherapy, yet survival remains poor for many patients.
Scientists have long believed that cancer cells rely heavily on glucose, or blood sugar, for energy. A ketogenic diet is very low in carbohydrates and high in fat, forcing the body to burn fat instead of sugar. This produces ketones, which healthy brain cells can use as fuel. Researchers hoped that while healthy cells switch to ketones, tumor cells would struggle without their preferred energy source.
However, newer research has shown that the biology is much more complex than first believed. Some glioma cells may also be able to use fats and amino acids for energy, making it harder to slow tumor growth through dietary changes alone.
Largest Review So Far Examines Human Evidence
The research team analyzed 23 human studies involving 306 patients with malignant gliomas. These included randomized controlled trials, quasi-experimental studies, case series, and case reports evaluating several versions of ketogenic diets, including the classic ketogenic diet, modified ketogenic diet, modified Atkins diet, and medium-chain triglyceride ketogenic diet. Some studies also combined the diet with periods of fasting.
One encouraging finding was that most patients successfully entered ketosis, meaning their bodies switched from using glucose as their primary fuel to burning fat. Blood glucose levels often fell, ketone levels generally increased, and most patients experienced only modest weight loss while following the diet.
About one in five participants eventually stopped following the diet. The most common reasons included its restrictive nature, disease progression, digestive problems, concerns about quality of life, and the practical challenges of maintaining such a strict eating plan during daily life.
This
w.thailandmedical.news/">Medical News report highlights that the biggest unanswered question remains whether these metabolic changes actually translate into better outcomes for patients.
The strongest evidence came from randomized clinical trials, which found no statistically significant improvement in overall survival or progression-free survival compared with patients receiving standard diets. Although several smaller studies and individual case reports described patients who survived much longer than expected, these encouraging results were inconsistent and often involved only a handful of carefully selected patients.
Interestingly, some studies found that patients who achieved lower blood glucose levels during treatment appeared to have better outcomes. This suggests that controlling glucose metabolism may be more important than simply producing ketones, although much larger studies will be needed to confirm this possibility.
Safety Results Are Generally Encouraging
Despite concerns that ketogenic diets are difficult to tolerate, the review found that they were generally safe when patients were monitored by healthcare professionals.
Most reported side effects were mild and included constipation, nausea, diarrhea, fatigue, headaches, dizziness, appetite loss, and temporary weight loss. Serious complications directly linked to the diet were uncommon. While many patients completed the dietary programs successfully, maintaining strict carbohydrate restriction over several months remained one of the biggest obstacles to long-term adherence.
What the Findings Mean for Patients
The review provides one of the clearest assessments so far of ketogenic diets as an additional treatment for malignant gliomas. While the diets consistently produce the desired metabolic changes and appear relatively safe under medical supervision, there is still no reliable clinical evidence showing that they help patients live longer or significantly improve their quality of life. The researchers conclude that much larger, carefully designed clinical trials are urgently needed to determine whether specific groups of patients could benefit from ketogenic therapy and to identify the most effective dietary strategies before such diets can become part of standard brain cancer care.
The study findings were published in the peer reviewed journal: Nutrients.
https://www.mdpi.com/2072-6643/18/13/2166
For the latest on diets and cancer, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/diets-and-nutrition
Share
Tweet
Share
